Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

KASHI CLINICAL LABORATORIES, LLC

NPI: 1861617680 · PORTLAND, OR 97219 · Clinical Medical Laboratory · NPI assigned 04/16/2007

$5.03M
Total Medicaid Paid
255,093
Total Claims
115,570
Beneficiaries
52
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMEHDIZADEH KASHI, ZAHRA (CEO & LAB DIRECTOR)
NPI Enumeration Date04/16/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,470 $907K
2019 19,449 $1.41M
2020 21,341 $423K
2021 37,885 $407K
2022 71,249 $705K
2023 60,475 $690K
2024 38,224 $486K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 31,459 14,284 $1.87M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 5,852 1,729 $794K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 7,824 2,906 $792K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 50,747 11,945 $443K
80307 8,956 4,362 $354K
0087U 584 530 $278K
H0048 Alcohol and/or other drug testing: collection and handling only, specimens other than blood 22,384 9,291 $254K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 32,086 7,414 $93K
36415 19,312 12,024 $22K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 4,895 1,061 $17K
80053 7,295 5,479 $12K
85025 8,681 6,113 $11K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 742 339 $9K
87635 1,288 405 $9K
84443 3,453 2,732 $8K
82306 1,579 1,284 $7K
83036 4,223 3,425 $7K
80048 4,762 3,211 $6K
80061 2,668 2,153 $6K
0088U 59 56 $5K
83880 775 616 $4K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 19,100 11,999 $3K
82607 1,011 808 $2K
85027 1,793 1,382 $2K
82728 780 646 $1K
87088 1,331 1,037 $1K
87086 1,327 1,036 $1K
83735 1,058 731 $1K
82140 298 213 $1K
87077 905 731 $1K
87186 833 674 $1K
80164 476 371 $969.59
81000 1,701 1,323 $948.75
82746 445 364 $808.30
84439 661 501 $778.52
87502 151 91 $737.66
83540 644 517 $736.91
86140 514 298 $679.89
83550 532 429 $629.97
85610 998 452 $594.26
83970 67 52 $239.29
80069 216 149 $139.84
85651 170 115 $126.48
87798 134 75 $122.80
80177 30 24 $120.64
84153 32 27 $115.83
80159 13 12 $42.33
84100 57 37 $36.52
82570 35 27 $18.15
82043 15 13 $8.10
85018 25 13 $4.98
87634 117 64 $0.00